Naveen Kulkarni, MD

Publications

• Neoadjuvant chemotherapy for pancreatic cancer: Quality over quantity.

  (Thalji SZ, Aldakkak M, Christians KK, Clarke CN, George B, Kamgar M, Erickson BA, Hall WA, Chisholm P, Kulkarni N, Doucette S, Evans DB, Tsai S.) J Surg Oncol. 2023 Jul;128(1):41-50 PMID: 36960919 SCOPUS ID: 2-s2.0-85152449940 03/25/2023

• Postoperative surveillance of pancreatic ductal adenocarcinoma (PDAC) recurrence: practice pattern on standardized imaging and reporting from the society of abdominal radiology disease focus panel on PDAC.

  (Chu LC, Wang ZJ, Kambadakone A, Hecht EM, He J, Narang AK, Laheru DA, Arif-Tiwari H, Bhosale P, Bolan CW, Brook OR, Bezuidenhout AF, Do RKG, Galgano SJ, Goenka AH, Guimaraes AR, Hough DM, Kulkarni N, Le O, Luk L, Mannelli L, Rosenthal M, Sangster G, Shah ZK, Soloff EV, Tolat PP, Zins M, Fishman EK, Tamm EP, Zaheer A.) Abdom Radiol (NY). 2023 Jan;48(1):318-339 PMID: 36241752 SCOPUS ID: 2-s2.0-85140245527 10/15/2022

• Image Quality Evaluation in Dual-Energy CT of the Chest, Abdomen, and Pelvis in Obese Patients With Deep Learning Image Reconstruction.

  (Fair E, Profio M, Kulkarni N, Laviolette PS, Barnes B, Bobholz S, Levenhagen M, Ausman R, Griffin MO, Duvnjak P, Zorn AP, Foley WD.) J Comput Assist Tomogr. 2022 Jul-Aug 01;46(4):604-611 PMID: 35483100 SCOPUS ID: 2-s2.0-85134296786 04/29/2022

• Computed Tomography Techniques, Protocols, Advancements, and Future Directions in Liver Diseases.

  (Kulkarni NM, Fung A, Kambadakone AR, Yeh BM.) Magn Reson Imaging Clin N Am. 2021 Aug;29(3):305-320 PMID: 34243919 PMCID: PMC8388239 07/11/2021

• Adjuvant therapy rates and overall survival in patients with localized pancreatic cancer from high Area Deprivation Index neighborhoods.

  (Mora J, Krepline AN, Aldakkak M, Christians KK, George B, Hall WA, Erickson BA, Kulkarni N, Evans DB, Tsai S.) Am J Surg. 2021 Jul;222(1):10-17 PMID: 33308823 SCOPUS ID: 2-s2.0-85097458297 12/15/2020

• Total Neoadjuvant Therapy for Operable Pancreatic Cancer.

  (Kim RY, Christians KK, Aldakkak M, Clarke CN, George B, Kamgar M, Khan AH, Kulkarni N, Hall WA, Erickson BA, Evans DB, Tsai S.) Ann Surg Oncol. 2021 Apr;28(4):2246-2256 PMID: 33000372 SCOPUS ID: 2-s2.0-85091728559 10/02/2020

• CT Esophagography for Evaluation of Esophageal Perforation.

  (Norton-Gregory AA, Kulkarni NM, O'Connor SD, Budovec JJ, Zorn AP, Desouches SL.) Radiographics. 2021;41(2):447-461 PMID: 33577418 SCOPUS ID: 2-s2.0-85102538367 02/13/2021

• Radiographic patterns of first disease recurrence after neoadjuvant therapy and surgery for patients with resectable and borderline resectable pancreatic cancer.

  (Barnes CA, Aldakkak M, Christians KK, Clarke CN, Dua K, George B, Ritch PS, Kamgar M, Hall WA, Kulkarni N, Erickson BA, Evans DB, Tsai S.) Surgery. 2020 Sep;168(3):440-447 PMID: 32641278 SCOPUS ID: 2-s2.0-85087345792 07/10/2020

• White paper on pancreatic ductal adenocarcinoma from society of abdominal radiology's disease-focused panel for pancreatic ductal adenocarcinoma: Part II, update on imaging techniques and screening of pancreatic cancer in high-risk individuals.

  (Kulkarni NM, Mannelli L, Zins M, Bhosale PR, Arif-Tiwari H, Brook OR, Hecht EM, Kastrinos F, Wang ZJ, Soloff EV, Tolat PP, Sangster G, Fleming J, Tamm EP, Kambadakone AR.) Abdom Radiol (NY). 2020 Mar;45(3):729-742 PMID: 31768594 SCOPUS ID: 2-s2.0-85076204261 11/27/2019

• White paper on pancreatic ductal adenocarcinoma from society of abdominal radiology's disease-focused panel for pancreatic ductal adenocarcinoma: Part I, AJCC staging system, NCCN guidelines, and borderline resectable disease.

  (Kulkarni NM, Soloff EV, Tolat PP, Sangster GP, Fleming JB, Brook OR, Wang ZJ, Hecht EM, Zins M, Bhosale PR, Arif-Tiwari H, Mannelli L, Kambadakone AR, Tamm EP.) Abdom Radiol (NY). 2020 Mar;45(3):716-728 PMID: 31748823 SCOPUS ID: 2-s2.0-85075391594 11/22/2019

• Structured Reporting in Ultrasound.

  (O'Connor SD, Kulkarni NM, Griffin MO Jr, Baruah D, Sudakoff GS, Tolat PP.) Ultrasound Q. 2020 Mar;36(1):1-5 PMID: 31107426 SCOPUS ID: 2-s2.0-85081139751 05/21/2019

• Impact of Neoadjuvant Chemoradiation on Pathologic Response in Patients With Localized Pancreatic Cancer.

  (Wittmann D, Hall WA, Christians KK, Barnes CA, Jariwalla NR, Aldakkak M, Clarke CN, George B, Ritch PS, Riese M, Khan AH, Kulkarni N, Evans J, Erickson BA, Evans DB, Tsai S.) Front Oncol. 2020;10:460 PMID: 32351886 PMCID: PMC7175033 SCOPUS ID: 2-s2.0-85084010622 05/01/2020